Oruka Therapeutics, Inc. (ORKA) Reports Q3 Loss of $1.46
Tweet
Share
E-mailGet Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics, Inc. (NASDAQ: ORKA) reported Q3 EPS of ($1.46).
For earnings history and earnings-related data on Oruka Therapeutics, Inc. (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Home Depot (HD) call put ratio 1.3 calls to 1 put into quarter results
- Babcock & Wilcox (BW) call put ratio 1 call to 3.4 puts with a focus on August 10 puts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
